Life-science briefing: Thursday, March 27, 2008
TODAY’S HEADLINES:
Breathe Tech raises $15M for respiratory disease (release)
Protein-drug maker Pieris takes in €25M (release)
Apthera takes in $2.1M toward cancer vaccine (VentureWire)
Breathe Tech raises $15M for respiratory disease – Breathe Technologies, a Fremont, Calif., medical device maker, raised $15 million in a second round of funding. Investors included Kleiner Perkins Caufield & Byers, Synergy Partners International, Delphi Ventures and Life Science Angels.
Breathe is developing “compact” and “lightweight” respiratory systems for the hospital and home markets, and… Continue Reading
Life-science briefing: Tuesday, March 25, 2008
TODAY’S HEADLINES:
Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker Spiration gets $19M (release)
Sample-prep startup Protein Discovery pulls in $10M (release)
Inogen takes in $13M for portable oxygen device (VentureWire)
Healthcare IT concern Medaptus raises $11M for expansion (VentureWire)
Contract lab Synexis raises $14M (peHUB)
Medical-device VC firm BioStar Ventures takes in $24M of $80M fund (peHUB)
Halsa Pharma gets $250K for “natural” obesity-control treatment (release)
Diagnostics provider Lab21 acquires NPTech (peHUB)
Galil Medical names Martin Emerson CEO (release)
Antibody-discovery startup Adimab raises new funding – Lebanon,… Continue Reading
IPO roundup: MAP Pharma’s mixed reception, other recent filings
MAP Pharmaceuticals, the Mountain View, Calif., specialty pharma, had a mixed reception to its IPO Friday. The company priced its shares at $12, below its anticipated range of $14 to $16, raising up to $69 million — substantially less than the $92 million it might have pulled in. Investors, however, reacted positively and pushed up the shares 11 percent to $13.35.
MAP reformulates existing drugs in order to deliver them via inhalers. Its leading product is… Continue Reading
Life sciences briefing: Wednesday, Aug. 15, 2007
(UPDATED at 5:55pm PT: See below.)
Featured companies: Sierra Surgical Technologies, HerbalScience Nutraceuticals, Topigen Pharmaceuticals, EKR Therapeutics, Molecular Partners, Celsense, Glucose Sensing Technologies, Falcon Genomics, Waters, Calorimetry Sciences, Parion Sciences, Gilead Sciences, Isto Technologies, Fluidnet, NABsys
Sierra Surgical raises $7.1M — Palo Alto, Calif.-based Sierra Surgical Technologies, a developer of female sterilization technology, raised $7.1 million in a first funding round, PE Hub reports, citing a regulatory filing. Alta Partners and De Novo Ventures provided the funding.
Singapore’s HerbalScience raises… Continue Reading